Hormone expert Dr John Stevenson told ITV News that the latest study into hormone replacement therapy shows it is "a safe treatment".
– Dr Louise Schierback, co-author of the Danish study into HRT
These results matter because medical practitioners and women have been anxious of HRT for the past decade. This has led to a poorer quality of life for numerous women around menopause.
- Researchers in Denmark examined 1,000 women who began the study when they were aged between 45 and 58.
- Half of the group were given HRT which was started early after the menopause and the control group received no treatment.
- The study found that after 10 years, 33 women in the control group had died or suffered heart failure or a heart attack compared with just 16 women who were given HRT.
- 36 women in the HRT group were treated for cancer compared with 39 in the control group
- 10 women in the HRT group were treated for breast cancer compared with 17 in the control group.
- Eleven women in the HRT group were treated for stroke compared with 14 in the control group.
Taking hormone replacement therapy (HRT) during the menopause can reduce the risk of heart failure and heart attacks, according to a study.
Researchers also say that HRT is not associated with increased risk of cancer or strokes.
HRT, which is used to relieve symptoms of the menopause, is a hotly debated subject between academics.
Previous studies have indicated the drugs could lead to an increased risk of breast cancer and heart disease.